Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice
Ahmed Nadeem, Sheikh F. Ahmad, Naif O. Al‐Harbi, et al.
Behavioural Brain Research (2019) Vol. 364, pp. 213-224
Closed Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Environmental pollutants and the immune response
Takafumi Suzuki, Takanori Hidaka, Yoshito Kumagai, et al.
Nature Immunology (2020) Vol. 21, Iss. 12, pp. 1486-1495
Closed Access | Times Cited: 248
Oxidative Stress in Autism Spectrum Disorder—Current Progress of Mechanisms and Biomarkers
Xukun Liu, Lin Jing, Huajie Zhang, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 113
Repetitive Restricted Behaviors in Autism Spectrum Disorder: From Mechanism to Development of Therapeutics
Junbin Tian, Xuping Gao, Li Yang
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 58
Differential regulation of Nrf2 is linked to elevated inflammation and nitrative stress in monocytes of children with autism
Ahmed Nadeem, Sheikh F. Ahmad, Laila Al‐Ayadhi, et al.
Psychoneuroendocrinology (2019) Vol. 113, pp. 104554-104554
Closed Access | Times Cited: 68
Antioxidants as a Potential Target against Inflammation and Oxidative Stress in Attention-Deficit/Hyperactivity Disorder
Lourdes Álvarez‐Arellano, Nadia González‐García, Marcela Salazar–García, et al.
Antioxidants (2020) Vol. 9, Iss. 2, pp. 176-176
Open Access | Times Cited: 60
The impact of glutathione metabolism in autism spectrum disorder
Geir Bjørklund, Monica Daniela Doşa, Michaël Maes, et al.
Pharmacological Research (2021) Vol. 166, pp. 105437-105437
Closed Access | Times Cited: 50
Systemic maternal inflammation promotes ASD via IL-6 and IFN-γ
Daniel Majerczyk, Elizabeth Ayad, Kari L. Brewton, et al.
Bioscience Reports (2022) Vol. 42, Iss. 11
Open Access | Times Cited: 35
An insight into sex-specific neurotoxicity and molecular mechanisms of DEHP: A critical review
Yiyun Liu, Zhiling Guo, Ruihong Zhu, et al.
Environmental Pollution (2022) Vol. 316, pp. 120673-120673
Closed Access | Times Cited: 29
Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled Trials
Gara Arteaga-Henríquez, Laura Gisbert, Josep Antoni Ramos‐Quiroga
CNS Drugs (2023) Vol. 37, Iss. 3, pp. 215-229
Open Access | Times Cited: 18
Exposure to the plasticizer, Di-(2-ethylhexyl) phthalate during juvenile period exacerbates autism-like behavior in adult BTBR T + tf/J mice due to DNA hypomethylation and enhanced inflammation in brain and systemic immune cells
Ahmed Nadeem, Naif O. Al‐Harbi, Sheikh F. Ahmad, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 109, pp. 110249-110249
Closed Access | Times Cited: 33
Profiles of urine and blood metabolomics in autism spectrum disorders
Narueporn Likhitweerawong, Chanisa Thonusin, Nonglak Boonchooduang, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 7, pp. 1641-1671
Open Access | Times Cited: 33
Neurohormetic phytochemicals in the pathogenesis of neurodegenerative diseases
Adeleh Sahebnasagh, Samira Eghbali, Fatemeh Saghafi, et al.
Immunity & Ageing (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 24
Mitochondrial dysfunction in cognitive neurodevelopmental disorders: Cause or effect?
Ayyappan Anitha, Ismail Thanseem, Mary Iype, et al.
Mitochondrion (2023) Vol. 69, pp. 18-32
Closed Access | Times Cited: 15
Anti-Inflammatory Therapeutic Mechanisms of Isothiocyanates: Insights from Sulforaphane
Solomon Habtemariam
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1169-1169
Open Access | Times Cited: 5
The role of isothiocyanate-rich plants and supplements in neuropsychiatric disorders: a review and update
Monica Ramakrishnan, Jed W. Fahey, Andrew W. Zimmerman, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 5
Investigating the Interplay Between the Nrf2/Keap1/HO-1/SIRT-1 Pathway and the p75NTR/PI3K/Akt/MAPK Cascade in Neurological Disorders: Mechanistic Insights and Therapeutic Innovations
R Mukherjee, R.S. Rana, Sidharth Mehan, et al.
Molecular Neurobiology (2025)
Closed Access
Navigating the Complexities of Neuronal Signaling and Targets in Neurological Disorders: From Pathology to Therapeutics
Divya Choudhary, Muhammad Imran Khan, Zuber Khan, et al.
European Journal of Pharmacology (2025), pp. 177417-177417
Closed Access
Natural sulfur compounds in mental health and neurological disorders: insights from observational and intervention studies
Apeksha Rana, Ashutosh Katiyar, Alok Arun, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double‐blind, placebo‐controlled clinical trial
Sara Momtazmanesh, Zeinab Amirimoghaddam‐Yazdi, Hossein Sanjari Moghaddam, et al.
Psychiatry and Clinical Neurosciences (2020) Vol. 74, Iss. 7, pp. 398-405
Open Access | Times Cited: 38
Aggravation of autism-like behavior in BTBR T+tf/J mice by environmental pollutant, di-(2-ethylhexyl) phthalate: Role of nuclear factor erythroid 2-related factor 2 and oxidative enzymes in innate immune cells and cerebellum
Ahmed Nadeem, Sheikh F. Ahmad, Naif O. Al‐Harbi, et al.
International Immunopharmacology (2020) Vol. 91, pp. 107323-107323
Closed Access | Times Cited: 38
Cruciferous vegetables: rationale for exploring potential salutary effects of sulforaphane-rich foods in patients with chronic kidney disease
L. Cardozo, Lívia Alvarenga, Márcia Ribeiro, et al.
Nutrition Reviews (2020) Vol. 79, Iss. 11, pp. 1204-1224
Open Access | Times Cited: 38
Sulforaphane, an Nrf-2 Agonist, Modulates Oxidative Stress and Inflammation in a Rat Model of Cuprizone-Induced Cardiotoxicity and Hepatotoxicity
Ghadha Ibrahim Fouad
Cardiovascular Toxicology (2023) Vol. 23, Iss. 1, pp. 46-60
Open Access | Times Cited: 12
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology
Martina Di Bartolomeo, Tibor Štark, Serena Di Martino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3907-3907
Open Access | Times Cited: 12
A Brief Overview of Neutrophils in Neurological Diseases
Supriya Chakraborty, Zeynab Tabrizi, Nairuti Nikhil Bhatt, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 743-743
Open Access | Times Cited: 11
Therapeutic efficacy of sulforaphane in autism spectrum disorders and its association with gut microbiota: animal model and human longitudinal studies
Jiexian Yang, Li He, Si Dai, et al.
Frontiers in Nutrition (2024) Vol. 10
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top